Elevated levels of CRP, IL-1beta, IL-6, and TNF-alpha have been consistently linked to an increased risk of NAFLD [26], with many studies supporting CRP’s utility in NAFLD diagnosis and severity assessment [27]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.